TRMP: a database of therapeutically relevant multiple pathways

UNLABELLED Disease processes often involve crosstalks between proteins in different pathways. Different proteins have been used as separate therapeutic targets for the same disease. Synergetic targeting of multiple targets has been explored in combination therapy of a number of diseases. Potential harmful interactions of multiple targeting have also been closely studied. To facilitate mechanistic study of drug actions and a more comprehensive understanding the relationship between different targets of the same disease, it is useful to develop a database of known therapeutically relevant multiple pathways (TRMPs). Information about non-target proteins and natural small molecules involved in these pathways also provides useful hint for searching new therapeutic targets and facilitate the understanding of how therapeutic targets interact with other molecules in performing specific tasks. The TRMPs database is designed to provide information about such multiple pathways along with related therapeutic targets, corresponding drugs/ligands, targeted disease conditions, constituent individual pathways, structural and functional information about each protein in the pathways. Cross links to other databases are also introduced to facilitate the access of information about individual pathways and proteins. AVAILABILITY This database can be accessed at http://bidd.nus.edu.sg/group/trmp/trmp.asp and it currently contains 11 entries of multiple pathways, 97 entries of individual pathways, 120 targets covering 72 disease conditions together with 120 sets of drugs directed at each of these targets. Each entry can be retrieved through multiple methods including multiple pathway name, individual pathway name and disease name. SUPPLEMENTARY INFORMATION http://bidd.nus.edu.sg/group/trmp/sm.pdf

[1]  Donald E. Nicholson.  IUBMB‐Nicholson metabolic pathways charts , 2001 .

[2]  Gary D Bader,et al.  BIND--The Biomolecular Interaction Network Database. , 2001, Nucleic acids research.

[3]  E. Stein,et al.  Pharmacotherapy for dyslipidaemia – current therapies and future agents , 2003, Expert opinion on pharmacotherapy.

[4]  G. Caramori,et al.  Cross‐talk between pro‐inflammatory transcription factors and glucocorticoids , 2001, Immunology and cell biology.

[5]  Debbie A Lewis.  Antiretroviral combination therapy for HIV infection. , 2003, Dental update.

[6]  Yoshihiro Nishioka,et al.  Combination Therapy with Granisetron, Methylprednisolone and Droperidol as an Antiemetic Prophylaxis in CDDP-Induced Delayed Emesis for Gynecologic Cancer , 2002, Oncology.

[7]  Ioannis Xenarios,et al.  DIP, the Database of Interacting Proteins: a research tool for studying cellular networks of protein interactions , 2002, Nucleic Acids Res..

[8]  Jean-Pierre Julien,et al.  Efficient three‐drug cocktail for disease induced by mutant superoxide dismutase , 2003, Annals of neurology.

[9]  Xin Chen,et al.  Internet resources for proteins associated with drug therapeutic effects, adverse reactions and ADME. , 2003, Drug discovery today.

[10]  K. Korach,et al.  Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Zemel,et al.  Agouti/melanocortin interactions with leptin pathways in obesity. , 2009, Nutrition reviews.

[12]  Lynda B. M. Ellis,et al.  The University of Minnesota Biocatalysis/Biodegradation Database: post-genomic data mining , 2003, Nucleic Acids Res..

[13]  S. Woods,et al.  Central nervous system control of food intake , 2000, Nature.

[14]  J. D. Elliott,et al.  Drug discovery in the next millennium. , 2000, Annual review of pharmacology and toxicology.

[15]  Peter D. Karp,et al.  The EcoCyc Database , 2002, Nucleic Acids Res..

[16]  A. Hopkins,et al.  The druggable genome , 2002, Nature Reviews Drug Discovery.

[17]  Susumu Goto,et al.  The KEGG databases at GenomeNet , 2002, Nucleic Acids Res..

[18]  Hiroshi Takayanagi,et al.  T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ , 2000, Nature.

[19]  He Qiang,et al.  The interface between ErbB and non-ErbB receptors in tumor invasion: clinical implications and opportunities for target discovery. , 2003, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[20]  Yoshihiro Uno,et al.  Cross‐Talk among Noradrenaline, Adenosine and Protein Kinase C in the Mechanisms of Ischemic Preconditioning in Rabbits , 2003, Journal of cardiovascular pharmacology.

[21]  N. Gough,et al.  Signal Transduction Pathways as Targets for Therapeutics , 2001, Science's STKE.

[22]  Ata A. Abdel-Latif,et al.  Cross Talk between Cyclic AMP and the Polyphosphoinositide Signaling Cascade in Iris Sphincter and Other Nonvascular Smooth Muscle , 1996, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[23]  J. Vilček,et al.  Inhibition of IκB Kinase Activity by Sodium Salicylate in Vitro Does Not Reflect Its Inhibitory Mechanism in Intact Cells* , 2000, The Journal of Biological Chemistry.

[24]  X. Chen,et al.  TTD: Therapeutic Target Database , 2002, Nucleic Acids Res..

[25]  R. Gaynor,et al.  The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β , 1998, Nature.

[26]  Ron D. Appel,et al.  ExPASy: the proteomics server for in-depth protein knowledge and analysis , 2003, Nucleic Acids Res..

[27]  Howard J Federoff,et al.  Current Treatment for Alzheimer Disease and Future Prospects , 2003, Alzheimer disease and associated disorders.

[28]  A. Sands,et al.  Knockouts model the 100 best-selling drugs—will they model the next 100? , 2003, Nature Reviews Drug Discovery.

[29]  J. Drews.  Drug discovery: a historical perspective. , 2000, Science.

[30]  Sui Huang.  Rational drug discovery: what can we learn from regulatory networks? , 2002, Drug discovery today.

[31]  S. Mason,et al.  Combination Therapy with Indinavir, Ritonavir, and Delavirdine and Nucleoside Reverse Transcriptase Inhibitors in Patients with HIV/AIDS Who Have Failed Multiple Antiretroviral Combinations , 2001, HIV clinical trials.

[32]  Edgar Wingender,et al.  TRANSPATH: An integrated database on signal transduction and a tool for array analysis , 2003, Nucleic Acids Res..

[33]  Alan Dove,et al.  Proteomics: translating genomics into products? , 1999, Nature Biotechnology.

[34]  P. Philip,et al.  Systemic therapy for advanced pancreatic cancer , 2002, Expert review of anticancer therapy.

[35]  Tsuguchika Kaminuma,et al.  A Database for Cell Signaling Networks , 1998, J. Comput. Biol..

[36]  Arul M. Chinnaiyan,et al.  Molecular Cross-talk between the TRAIL and Interferon Signaling Pathways * , 2001 .

[37]  Gregory D. Schuler,et al.  Database resources of the National Center for Biotechnology , 2003, Nucleic Acids Res..

[38]  Terry Gaasterland,et al.  The metabolic pathway collection from EMP: the enzymes and metabolic pathways database , 1996, Nucleic Acids Res..

[39]  古市 恵美子,et al.  シグナル伝達情報と遺伝情報を統合したSPAD(Signaling Pathway Database)の構築 , 1996 .